Emergence of co-production of plasmid-mediated AmpC beta-lactamase and ESBL in cefoxitin-resistant uropathogenic Escherichia coli

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 9, 2016, Pages 1449-1454

  Ghosh, B ^a   Mukherjee, M ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BENZENEBORONIC ACID; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE TEM 1; CEFEPIME; CEFOXITIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; NITROFURANTOIN; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BIOTECHNOLOGICAL PRODUCTION; CONTROLLED STUDY; ENZYME SYNTHESIS; GENE PRODUCT; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPLICON; URINE CULTURE; UROPATHOGENIC ESCHERICHIA COLI; ANALYSIS; BACTERIUM CONJUGATION; CLASSIFICATION; DISK DIFFUSION; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETIC VARIATION; GENETICS; GENOTYPE; HORIZONTAL GENE TRANSFER; HUMAN; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGY; SECRETION (PROCESS); URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOXITIN; CONJUGATION, GENETIC; DISK DIFFUSION ANTIMICROBIAL TESTS; ESCHERICHIA COLI INFECTIONS; GENE TRANSFER, HORIZONTAL; GENETIC VARIATION; GENOTYPE; HUMANS; INDIA; MOLECULAR TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84973094043     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2683-z     Document Type: Article

References (40)

1. Akram M, Shahid M, Khan AU (2007) Etiology and antibiotic resistance pattern of community-acquired urinary tract infection in JNMC Hospital Aligarh India. Ann Clin Microbiol Antimicrob 6:4–10
2. Nicolle LE (2007) Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin N Am 35(1):1–12
3. Gales AC, Jones RN, Gordon KA et al (2000) Activity and spectrum of 22 antimicrobial agents tested against urinary tract pathogens in hospitalised patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998). J Antimicrob Chemother 45:295–303
4. Gupta K, Sahm DF, Mayfield D et al (2001) Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 33:89–94
5. Pérez-Pérez FJ, Hanson ND (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40(6):2153–2162
6. Mammeri H, Nazic H, Naas T et al (2004) AmpC β-Lactamase in an Escherichia coli Clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 48(10):4050–4053
7. Taneja N, Rao P, Arora J et al (2008) Occurrence of ESBL & Amp-C β-lactamases and susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 127:85–88
8. Manoharan A, Sugumar M, Kumar A et al (2012) Phenotypic and molecular characterization of AmpC βlactamases among Escherichia coli Klebsiella spp & Enterobacter spp from five Indian medical centers. Indian J Med Res 135:359–364
9. Mohamudha PR, Harish BN, Parija SC (2012) Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in India. Indian J Med Res 135:114–119
10. Chakraborty A, Adhikari P, Shenoy S et al (2014) Characterization of Plasmid mediated AmpC producing Escherechia coli clinical isolates from tertiary care hospital in South India. Indian J Pathol Microbiol 57(2):255–258
11. Haenni M, Châtre P, Madec JY (2014) Emergence of Escherichiacoli producing extended-spectrum AmpCβ-lactamases(ESAC)in animals. Frontiers Microbiol 5(53):1–7
12. Thomson KS (2001) Controversies about extended-spectrum and AmpC β-lactamases. Emerg Infect Dis 7:333–336
13. Pfeifer Y, Cullik A, Witte W (2010) Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 300:371–379
14. Swaminathan B, Barrett T, Hunter SB et al (2001) The molecular subtyping network for foodborne disease surveillance in the United States. Emerg Infect Dis 7:382–389
15. Hanson ND (2003) AmpC β-lactamases: what do we need to know for the future? J Antimicrob Chemother 52:2–4
16. Papanicolaou GA, Medeiros AA, Jacoby GA (1990) Novel plasmid mediated β-lactamases(MIR-1) conferring resistance to oxyimino and α methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 34:2200–2209
17. Black JA, Moland ES, Thomson KS (2005) AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β –lactamases. J Clin Microbiol 43:3110–3113
18. Myer K (2001) Methods in biochemical identification of bacteria. Myer’s and Koshi’s manual of diagnostic procedures in medical microbiology and immunology/serology, 2nd ed. Department of Clinical Microbiology, Christian Medical College, Vellore, pp 195–202
19. CLSI; Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne PA
20. Coudron PE (2005) Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli and Proteus mirabilis. J Clin Microbiol 43:4163–4167
21. Kado CI, Liu ST (1981) Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 145(3):1365–1373
22. MendoncaN LD, Castro AP et al (2006) ctxm-15, oxa-30 and tem-1 producing Escherechia coli in two Portugese regions. J Antimicrob Chemother 57:1014–1016
23. Carattoli A, Bertini A, Villa L et al (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228
24. Sasirekha B, Shivakumar S (2012) Occurrence of plasmid-mediated AmpC b-lactamases among Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care hospital in Bangalore. Indian J Microbiol 52(2):174–179
25. Dhanashree B, Mallya SP (2012) Molecular typing of enteropathogenic Escherichia coli from diarrheagenic stool samples. J Clin Diagn Res 6(3):400–404
26. Farshad S, Emamghorashi F (2009) The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection. Saudi J Kidney Dis Transpl 20:613–617
27. Kaluzna M, Ferrante P, Sobiczewski P, Scortichini M (2010) Characterization and genetic diversity of pseudomonas syringae from stone fruits and hazelnut using repetitive-pcr and mlst. J Plant Pathol 92:781–787
28. Jacoby GA (2009) AmpC betalactamases. Clin Microbiol Rev 22(1):161–182
29. Singhal S, Mathur T, Khan S et al (2005) Evaluation of methods for AmpC β-lactamase in Gram-negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 23:120–124
30. Gupta V (2007) An update on newer betalactamases. Indian J Med Res 126(5):417–427
31. Ratna AK, Menon I, Kapur I et al (2003) Occurrence and detection of AmpC β-lactamases at a referral hospital in Karnataka. Indian J Med Res 118:29–32
32. Hemalatha PM, Sekar U et al (2007) Detection of AmpC β-lactamases production in Escherichia coli and Klebsiella by an inhibitor based method. Indian J Med Res 126:220–223
33. Arora S, Bal M (2005) AmpC b-lactamase producing bacterial isolates from Kolkata hospital. Indian J Med Res 122:224–233
34. Mata C, Miró E, Alvarado A et al (2012) Plasmid typing and genetic context of AmpC βlactamases in Enterobacteriaceae lacking inducible chromosomal AmpC genes: findings from a Spanish hospital 1999–2007. J Antimicrob Chemother 67:115–122
35. Alonso N, Miro E, Pascual V et al (2016) Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates. Int J Antimicrob Agents 47:62–68
36. Ahmed SF, Ali MMM, Mohamed ZK et al (2014) Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community. Ann Clin Microbiol Antimicrob 13:22
37. Sallem RB, Slama KB, Rojo-Bezares B et al (2014) IncI1 Plasmids carrying blaCTX-M-1 or blaCMY-2 genes in Escherichia coli from healthy humans and animals in Tunisia. Microb Drug Resist. doi:10.1089/mdr.2013.0224
38. Galán-Sánchez F, Aznar-Marín P, Marín-Casanova P et al (2014) Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates. APMIS 122(9):796–799
39. Bajaj P, Singh NS, Kanaujia PK et al (2015) Distribution and molecular characterization of genes encoding CTX-M and AmpC β-lactamases in Escherichia coli isolated from an Indian urban aquatic environment. Sci Total Environ 505:350–356
40. Ibrahim DR, Dodd CE, Stekel DJ et al (2016) Multidrug resistant, extended spectrum β-lactamase (ESBL)-producing Escherichia coli isolated from a dairy farm. FEMS Microbiol Ecol 92 10.1093/femsec/fiw01